热门资讯> 正文

Artiva Biotherapeutics GAAP每股收益为-0.83美元

2025-05-08 22:22

Artiva Biotherapeutics, Inc.(ARTV) 0

Artiva Biotherapeutics press release (NASDAQ:ARTV): Q1 GAAP EPS of -$0.83.
As of March 31, 2025, Artiva had cash, cash equivalents, and investments of $166.0 million which is expected to fund operations into Q2 2027.

More on Artiva Biotherapeutics

Historical earnings data for Artiva Biotherapeutics
Financial information for Artiva Biotherapeutics

推荐文章

风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。